Article
Follow-up Analysis of Intermediate-risk Prostate Cancer Patients Staged With Psma PET/CT
2026-04-21
Abstract excerpt
<title>Abstract</title> <p> <bold>Objective.</bold> Radiolabelled PSMA PET/CT has demonstrated high diagnostic accuracy in staging patients with intermediate-risk prostate cancer (PCa). However, its role on long-term prognosis and outcome prediction in this risk-group remains poorly defined. This study aimed to evaluate survival outcomes and identify prognostic factors in intermediate-risk PCa patients staged w...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 31d1ac4e-3165-5333-aa70-2037f924d65a
- DOI
- 10.21203/rs.3.rs-9347158/v1
